Miao Mo

3.4k total citations · 1 hit paper
96 papers, 2.0k citations indexed

About

Miao Mo is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Miao Mo has authored 96 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 43 papers in Cancer Research and 24 papers in Molecular Biology. Recurrent topics in Miao Mo's work include Breast Cancer Treatment Studies (27 papers), Global Cancer Incidence and Screening (9 papers) and Breast Lesions and Carcinomas (9 papers). Miao Mo is often cited by papers focused on Breast Cancer Treatment Studies (27 papers), Global Cancer Incidence and Screening (9 papers) and Breast Lesions and Carcinomas (9 papers). Miao Mo collaborates with scholars based in China, United States and United Kingdom. Miao Mo's co-authors include Ying Zheng, Jiong Wu, Wanghong Xu, Yanfei Liu, Qunye He, Dongming Peng, Xiheng Hu, Yao Zhu, Zhenbao Liu and Lin Qi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Miao Mo

93 papers receiving 2.0k citations

Hit Papers

Epidemiology and genomics of prostate cancer in Asian men 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miao Mo China 24 672 563 526 493 276 96 2.0k
Han Wu China 31 808 1.2× 625 1.1× 527 1.0× 298 0.6× 330 1.2× 92 2.5k
Claude Linassier France 28 786 1.2× 277 0.5× 738 1.4× 715 1.5× 236 0.9× 97 2.7k
Sally Temraz Lebanon 27 776 1.2× 462 0.8× 888 1.7× 405 0.8× 258 0.9× 97 2.1k
Feng Lin China 27 605 0.9× 318 0.6× 647 1.2× 600 1.2× 234 0.8× 75 2.0k
Jianhua Wang China 27 772 1.1× 542 1.0× 615 1.2× 522 1.1× 652 2.4× 111 2.5k
Linda E. Kelemen United States 27 632 0.9× 353 0.6× 638 1.2× 240 0.5× 140 0.5× 55 2.2k
Kamal S. Saini United States 24 697 1.0× 485 0.9× 1.2k 2.3× 327 0.7× 130 0.5× 88 2.4k
Andrew R. Clamp United Kingdom 24 734 1.1× 227 0.4× 739 1.4× 276 0.6× 222 0.8× 116 2.0k
Swati Kulkarni United States 24 492 0.7× 541 1.0× 747 1.4× 242 0.5× 189 0.7× 103 2.0k
Cláudia Marchetti Italy 33 719 1.1× 406 0.7× 968 1.8× 333 0.7× 649 2.4× 178 3.3k

Countries citing papers authored by Miao Mo

Since Specialization
Citations

This map shows the geographic impact of Miao Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miao Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miao Mo more than expected).

Fields of papers citing papers by Miao Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miao Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miao Mo. The network helps show where Miao Mo may publish in the future.

Co-authorship network of co-authors of Miao Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Miao Mo. A scholar is included among the top collaborators of Miao Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miao Mo. Miao Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaomeng, Li Zhang, Shi Wei, et al.. (2024). Post-mastectomy hypofractionated versus conventionally fractionated radiation therapy for patients receiving immediate breast reconstruction: Subgroup analysis of a phase III randomized trial. Clinical and Translational Radiation Oncology. 50. 100882–100882. 1 indexed citations
2.
Yang, Xin, Jianfeng Guo, Miao Mo, et al.. (2024). PdZn/CoSA‐NC Nanozymes with Highly Efficient SOD/CAT Activities for Treatment of Osteoarthritis via Regulating Immune Microenvironment. Advanced Functional Materials. 34(41). 28 indexed citations
3.
Yang, Zhaozhi, Jin Meng, Xin Mei, et al.. (2024). Brain Radiotherapy With Pyrotinib and Capecitabine in Patients With ERBB2-Positive Advanced Breast Cancer and Brain Metastases. JAMA Oncology. 10(3). 335–335. 10 indexed citations
5.
Mo, Miao, et al.. (2023). MIR663AHG as a competitive endogenous RNA regulating TGF‐β‐induced epithelial proliferation and epithelial–mesenchymal transition in benign prostate hyperplasia. Journal of Biochemical and Molecular Toxicology. 37(9). e23391–e23391. 7 indexed citations
6.
Ding, Rui, Yi Xiao, Miao Mo, et al.. (2022). Breast cancer screening and early diagnosis in Chinese women. Cancer Biology and Medicine. 19(4). 450–467. 42 indexed citations
7.
Wang, Zezhou, Miao Mo, Changming Zhou, et al.. (2021). Time‐varying effect of sex on prognosis of lung adenocarcinoma surgical patients in China. Thoracic Cancer. 12(11). 1699–1707. 3 indexed citations
8.
Li, Yangle, et al.. (2021). Competing endogenous RNA network analysis reveals pivotal ceRNAs in bladder urothelial carcinoma. Translational Andrology and Urology. 10(2). 797–808. 4 indexed citations
9.
Lv, Zhengtong, Jianlong Wang, Xuan Wang, et al.. (2021). Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer. Frontiers in Cell and Developmental Biology. 9. 666025–666025. 29 indexed citations
11.
Zhang, Bo, Peihua Liu, Yan Zhou, et al.. (2019). Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation. Life Sciences. 223. 29–37. 38 indexed citations
12.
Peng, Mei, Jun Deng, Sichun Zhou, et al.. (2019). Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth. Frontiers in Pharmacology. 10. 1159–1159. 19 indexed citations
13.
Liang, Fei, Zhenyu Wu, Miao Mo, et al.. (2019). Comparison of treatment effect from randomised controlled phase II trials and subsequent phase III trials using identical regimens in the same treatment setting. European Journal of Cancer. 121. 19–28. 20 indexed citations
14.
Mo, Miao, et al.. (2019). A novel scoring system based on hemostatic parameters predicts the prognosis of patients with advanced pancreatic cancer. Pancreatology. 19(2). 346–351. 19 indexed citations
16.
Li, Xiaoqiang, Miao Mo, Fei Wu, et al.. (2018). Artificial neural network models based on questionnaire survey for prediction of breast cancer risk among Chinese women in Shanghai. Tumori. 38(9). 883–893. 3 indexed citations
17.
Wu, Siyu, Miao Mo, Yujie Wang, et al.. (2016). Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management. OncoTargets and Therapy. Volume 9. 6829–6834. 9 indexed citations
18.
Mo, Miao, Ying Zheng, Guang‐Yu Liu, et al.. (2015). [Cost-effectiveness analysis of two breast cancer screening modalities in Shanghai, China].. PubMed. 37(12). 944–51. 3 indexed citations
19.
Jia, Xiaoqing, Hong Qi, Jingyi Cheng, et al.. (2015). Indispensability of Chemotherapy in Estrogen Receptor–Negative Early Breast Cancer in Elderly Women with Diabetes Mellitus. Diabetes Technology & Therapeutics. 17(4). 248–254. 1 indexed citations
20.
Mo, Miao, Mi Zhou, Lu Wang, et al.. (2015). CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells. PLoS ONE. 10(3). e0119506–e0119506. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026